Hester Biosciences has informed that a Meeting of the Board of Directors of the Company will be held on May 07, 2016, to consider the Audited Standalone and Consolidated Financial Results for the quarter and year ended on March 31, 2016. Further, in compliance with SEBI (Prohibition of Insider Trading) Regulations, the ‘Trading Window’ for dealing in equity shares of the Company shall remain closed from April 27, 2016 to May 09, 2016.
The above information is a part of company’s filings submitted to BSE.